BRCA1/2 variants of unknown significance in hereditary breast and ovarian cancer (HBOC) syndrome: looking for the hidden meaning
Article in Critical Reviews in Oncology/Hematology (February 2022)
The most recent citing publications are shown below. View all 43 publications that cite this research output on Dimensions.
Imprecise Medicine: BRCA2 Variants of Uncertain Significance (VUS), the Challenges and Benefits to Integrate a Functional Assay Workflow with Clinical Decision Rules
Article in Genes (May 2021)
Prevalence of Variant Reclassification Following Hereditary Cancer Genetic Testing
Article in JAMA (September 2018)